NCT04160338

Brief Summary

The aim of this study is to assess the effect of accelerated corneal collagen cross linking on corneal endothelium using the specular microscopy

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2019

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 13, 2019

Completed
18 days until next milestone

Study Start

First participant enrolled

December 1, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

November 13, 2019

Status Verified

November 1, 2019

Enrollment Period

1.8 years

First QC Date

November 8, 2019

Last Update Submit

November 8, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • endothelial cell count by specular microscopy.

    specular microscopy will be used to assess corneal endothelial cell count after accelerated corneal collagen cross linking

    from preoperatively to 6 months postoperatively

Secondary Outcomes (1)

  • endothelial cell morphology by specular microscopy.

    from preoperatively to 6 months postoperatively

Interventions

An informed written consent will be obtained from all patients that will be included in this study. Patients in this study will undergo specular microscopic examination of corneal endothelium before CXL procedure. Patients will be assigned to undergo accelerated (epithelium-off ,transepithelial ) CXL . Follow up specular microscopy will be done 3 months and 6 months after corneal collagen cross linking procedure .

Eligibility Criteria

Age16 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

patients who underwent accelerated corneal collagen cross linking

You may qualify if:

  • \. patients with mild to moderate corneal ectasia who are candidates for CXL.

You may not qualify if:

  • patients with advanced corneal ectasia with maximum keratometry readings \<56 diopters.
  • corneal pachymetry \>380um.
  • corneal scarring.
  • previous corneal surgeries (e.g intrastromal corneal ring segments)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (9)

  • Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg. 2008 May;34(5):796-801. doi: 10.1016/j.jcrs.2007.12.039.

    PMID: 18471635BACKGROUND
  • Subasinghe SK, Ogbuehi KC, Dias GJ. Current perspectives on corneal collagen crosslinking (CXL). Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1363-1384. doi: 10.1007/s00417-018-3966-0. Epub 2018 Apr 6.

    PMID: 29623463BACKGROUND
  • Mencucci R, Marini M, Paladini I, Sarchielli E, Sgambati E, Menchini U, Vannelli GB. Effects of riboflavin/UVA corneal cross-linking on keratocytes and collagen fibres in human cornea. Clin Exp Ophthalmol. 2010 Jan;38(1):49-56. doi: 10.1111/j.1442-9071.2010.02207.x.

    PMID: 20447101BACKGROUND
  • Wen D, Li Q, Song B, Tu R, Wang Q, O'Brart DPS, McAlinden C, Huang J. Comparison of Standard Versus Accelerated Corneal Collagen Cross-Linking for Keratoconus: A Meta-Analysis. Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):3920-3931. doi: 10.1167/iovs.18-24656.

    PMID: 30073363BACKGROUND
  • Kirgiz A, Eliacik M, Yildirim Y. Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus. Eye Vis (Lond). 2019 Jun 3;6:16. doi: 10.1186/s40662-019-0141-6. eCollection 2019.

    PMID: 31172016BACKGROUND
  • Zhang X, Zhao J, Li M, Tian M, Shen Y, Zhou X. Conventional and transepithelial corneal cross-linking for patients with keratoconus. PLoS One. 2018 Apr 5;13(4):e0195105. doi: 10.1371/journal.pone.0195105. eCollection 2018.

    PMID: 29621306BACKGROUND
  • Vazirani J, Bagga B, Taneja M. Persistent corneal edema after collagen cross-linking for keratoconus. Am J Ophthalmol. 2013 Apr;155(4):775. doi: 10.1016/j.ajo.2013.01.003. No abstract available.

    PMID: 23521904BACKGROUND
  • Sedaghat M, Bagheri M, Ghavami S, Bamdad S. Changes in corneal topography and biomechanical properties after collagen cross linking for keratoconus: 1-year results. Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):212-9. doi: 10.4103/0974-9233.151877.

    PMID: 25949080BACKGROUND
  • Abdel-Radi M, Abdelmohsen N, Abdelmotaal H, Abd El-Moneim MT. The effect of accelerated pulsed high-fluence corneal cross-linking on corneal endothelium; a prospective specular microscopy study. BMC Ophthalmol. 2023 Apr 18;23(1):163. doi: 10.1186/s12886-023-02912-6.

Study Officials

  • Mohamed T Abdelmonem, Professor

    Assiut Uneversity

    STUDY DIRECTOR
  • Hazem A Hazem, lecturer

    Assiut Uneversity

    STUDY DIRECTOR
  • Mahmoud A Abdelsalam, lecturer

    Assiut Uneversity

    STUDY DIRECTOR

Central Study Contacts

Naglaa MA Abdelmohsen, M.B.B.CH.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor

Study Record Dates

First Submitted

November 8, 2019

First Posted

November 13, 2019

Study Start

December 1, 2019

Primary Completion

September 1, 2021

Study Completion

March 1, 2022

Last Updated

November 13, 2019

Record last verified: 2019-11